home All News open_in_new Full Article
ACTG Presents Four Studies at CROI Describing Findings from SLIM LIVER
ACTG presented four SLIM LIVER study findings at CROI 2025, demonstrating that semaglutide can improve or resolve MASLD in people living with HIV. One study suggests epigenetic biomarkers in blood may predict treatment response. Additional findings cover semaglutide's impact on gut bacteria, heart health, metabolism, and liver inflammation in this population.
today 3 d. ago attach_file Events
attach_file
Society
attach_file
Other
attach_file
Politics
attach_file
Culture
attach_file
Society
attach_file
Events
attach_file
Other
attach_file
Other
attach_file
Events
attach_file
Events
attach_file
Economics
attach_file
Other
attach_file
Politics
attach_file
Events
attach_file
Transport
ID: 3513342620